Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
Launched by UNIVERSITY OF PALERMO · Mar 22, 2024
Trial Information
Current as of July 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether certain foods, especially wheat and gluten, might trigger attacks in people with Familial Mediterranean Fever (FMF). FMF is a condition that causes repeated episodes of fever and inflammation, leading to pain in the chest, abdomen, and joints. Researchers want to find out if eating wheat or other foods makes these episodes worse, and they are also looking at whether people with FMF feel sensitive to gluten or wheat, even if they don't have celiac disease or an allergy.
To participate in this study, you need to be between 6 months and 80 years old and diagnosed with FMF. Participants will be asked to complete questionnaires about their symptoms and diet. This research could help improve understanding of FMF and its possible links to diet, which may lead to better management of the condition. If you or someone you know has FMF and is interested in this study, it could be a valuable opportunity to contribute to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients, of both sexes, aged between 6 months and 80 years, affected by FMF, classified according to the Eurofever/PRINTO criteria.
- • Patients able to understand and complete the questionnaires independently (or, in the case of pediatric ones, analyzed through the answers provided by parents).
- Exclusion Criteria:
- • Patients aged \<6 months and \>80 years.
- • Patients unable to provide informed consent or complete the questionnaires.
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palermo, Sicily, Italy
Patients applied
Trial Officials
Antonio Carroccio, MD
Study Director
University of Palermo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported